A detailed history of Wny Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wny Asset Management, LLC holds 8,065 shares of ABT stock, worth $919,490. This represents 0.12% of its overall portfolio holdings.

Number of Shares
8,065
Previous 7,861 2.6%
Holding current value
$919,490
Previous $893,000 6.16%
% of portfolio
0.12%
Previous 0.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $20,548 - $22,937
204 Added 2.6%
8,065 $838,000
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $32,965 - $36,408
301 Added 3.98%
7,861 $893,000
Q4 2023

Feb 21, 2024

BUY
$90.19 - $110.4 $11,995 - $14,683
133 Added 1.79%
7,560 $832,000
Q3 2023

Dec 14, 2023

SELL
$95.53 - $114.62 $8,502 - $10,201
-89 Reduced 1.18%
7,427 $719,000
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $302 - $336
3 Added 0.04%
7,516 $819,000
Q1 2023

May 02, 2023

SELL
$96.86 - $114.01 $35,353 - $41,613
-365 Reduced 4.63%
7,513 $760,000
Q4 2022

Jan 25, 2023

BUY
$95.06 - $111.52 $34,221 - $40,147
360 Added 4.79%
7,878 $0
Q3 2022

Oct 25, 2022

BUY
$96.76 - $112.03 $3,967 - $4,593
41 Added 0.55%
7,518 $726,000
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $15,616 - $18,875
-153 Reduced 2.01%
7,477 $812,000
Q1 2022

Apr 19, 2022

SELL
$114.02 - $139.04 $5,244 - $6,395
-46 Reduced 0.6%
7,630 $908,000
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $45,172 - $55,310
-391 Reduced 4.85%
7,676 $1.08 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $5,833 - $6,453
50 Added 0.62%
8,067 $956,000
Q2 2021

Jul 14, 2021

BUY
$105.79 - $124.53 $213,907 - $251,799
2,022 Added 33.73%
8,017 $927,000
Q1 2021

Apr 20, 2021

BUY
$108.84 - $128.23 $189,381 - $223,120
1,740 Added 40.89%
5,995 $722,000
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $446,775 - $486,857
4,255 New
4,255 $465,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wny Asset Management, LLC Portfolio

Follow Wny Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wny Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wny Asset Management, LLC with notifications on news.